HemaSphere (Jun 2022)

P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN IN COMBINATION WITH A GAMMA-SECRETASE INHIBITOR (NIROGACESTAT) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-5 STUDY

  • A. Nooka,
  • S. Lonial,
  • S. Grosicki,
  • M. Hus,
  • K. Song,
  • T. Facon,
  • N. S. Callander,
  • V. Ribrag,
  • K. Uttervall,
  • H. Quach,
  • V. Vorobyev,
  • C.-K. Min,
  • S. Cheng,
  • L. M. Smith,
  • J. Yu,
  • T. Collingwood,
  • B. Holkova,
  • B. E. Kremer,
  • I. V. Gupta,
  • P. G. Richardson,
  • M. C. Minnema

DOI
https://doi.org/10.1097/01.HS9.0000846624.61314.38
Journal volume & issue
Vol. 6
pp. 829 – 830

Abstract

Read online

No abstracts available.